Home › Trial NCT04236102
KEBI-Cyto Study - Use of the Biocartis Idylla
- Trial IDNCT04236102
- StatusCompleted
- PhaseN/A
- Study typeInterventional
- SponsorRoyal Cornwall Hospitals Trust
- Enrollment55
- Start date2020-07-07
- ConditionsPancreatic Adenocarcinoma · Lung Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.